Cargando…
Retracted: The Value of Rivaroxaban Combined with Ticagrelor in Antithrombotic Therapy after PCI in Patients with Nonvalvular Atrial Fibrillation with Acute Coronary Syndrome
Autor principal: | and Alternative Medicine, Evidence-Based Complementary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371514/ https://www.ncbi.nlm.nih.gov/pubmed/37501878 http://dx.doi.org/10.1155/2023/9769353 |
Ejemplares similares
-
Retracted: Characteristics of the Dynamic Electrocardiogram in the Elderly with Nonvalvular Atrial Fibrillation Combined with Long R-R Intervals
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
The Value of Rivaroxaban Combined with Ticagrelor in Antithrombotic Therapy after PCI in Patients with Nonvalvular Atrial Fibrillation with Acute Coronary Syndrome
por: Liu, Zhengwang, et al.
Publicado: (2022) -
Retracted: The Effect of Renal Denervation on Cardiac Diastolic Function in Patients with Hypertension and Paroxysmal Atrial Fibrillation
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Investigating the Effects of Dapagliflozin on Cardiac Function, Inflammatory Response, and Cardiovascular Outcome in Patients with STEMI Complicated with T2DM after PCI
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: The Characteristics of Fear of Recurrence and the Effect of Cognitive-Behavioral Stress Management Intervention in Patients after Radiofrequency Ablation of Atrial Fibrillation
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)